Neko Health has secured a significant funding boost of $700 million to further develop its AI-powered body scan technology, expanding its presence in the United States. The company's preventive screening service combines various components including medical imaging, blood tests, proprietary sensors, and clinician review to provide early detection and personalized care for patients.
The Series C round was led by Lightspeed Venture Partners and co-led by O.G. Venture Partners. This investment marks a significant milestone in Neko Health's journey as it aims to transform the way healthcare is delivered. The funding will be used to drive innovation, scale up its operations, and expand its client base across the country.
Neko Health's AI body scan technology has already shown promising results in reducing medical errors and improving patient outcomes. With this new investment, the company plans to accelerate its development of advanced diagnostic tools and enhance its digital platform for secure data sharing and analytics. As Neko Health continues to push the boundaries of healthcare technology, it is likely that more clinics will soon follow suit by incorporating AI-powered body scans into their practices.